Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05362578 · ClinicalTrials.gov registry record · NA
Transcutaneous Electrical Acustimulation (TEA) for Gastroparesis
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT05362578 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 41 participants.
The verdict
NCT05362578, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
The device being studied, the Transcutaneous Electrical Accustimulator (TEA), will deliver weak electrical current at two specific points, one at the leg and the other at the arm at settings known to improve symptoms involving the digestive system. The study team would like to test if the device will impact the gastrointestinal (GI) symptoms and gastric motility in study participants with gastroparesis.
Interventions
- DEVICE transcutaneous electrical accustimulation at treatment point.
- DEVICE transcutaneous electrical accustimulation at sham point.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2022-09-08 |
| Est. Completion | 2025-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05362578
The ClinicalTrials.gov registry entry for NCT05362578 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which transcutaneous electrical accustimulation at treatment point. is the first listed.
NCT05362578 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05362578 about?
NCT05362578 is a clinical study titled "Transcutaneous Electrical Acustimulation (TEA) for Gastroparesis". The device being studied, the Transcutaneous Electrical Accustimulator (TEA), will deliver weak electrical current at two specific points, one at the leg and the other at the arm at settings known to improve symptoms involving the digestive system. The study team would like to test if the device wil...
What is the current status of trial NCT05362578?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2022-09-08. Estimated completion is 2025-02-28.
What interventions are being tested in trial NCT05362578?
The interventions under investigation include: transcutaneous electrical accustimulation at treatment point. (DEVICE), transcutaneous electrical accustimulation at sham point. (DEVICE).
Who is sponsoring clinical trial NCT05362578?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.